Ogura, Yuichiro
Iida, Tomohiro
Lee, Won Ki
Cheung, Chui Ming Gemmy
Mitchell, Paul
Leal, Sergio
Schmelter, Thomas
Ishibashi, Tatsuro
Funding for this research was provided by:
Bayer
Article History
Received: 23 June 2020
Accepted: 31 October 2020
First Online: 20 January 2021
Conflicts of interest
: Y. Ogura, Grant (Novartis, Santen, Boehringer Ingelheim), Consultant fee (Novartis, Santen, Senju, HOYA, Alcon Japan, Kowa, Jansen, Boehringer Ingelheim, Astellas), Lecture fee (Santen, Nikon, Wakamoto, Otsuka) and personal fees from Bayer in relation to the conduct of the PLANET study; T. Iida, Consultant fee, Advisory board member (Bayer, Novartis, Alcon Pharma, Chugai, Kowa); W. K. Lee, Consultant fee (Novartis, Bayer, Roche, Boehringer Ingelheim, Santen); C. M. G. Cheung, Consultant fee (Bayer, Novartis, Roche, Boehringer Ingelheim, Allergan), Lecture fee (Topcon, Zeiss), Grant (Bayer, Novartis, Topcon, Boehringer Ingelheim, Zeiss), Nonfinancial support (Bayer, Novartis, Roche, Topcon, Boehringer Ingelheim); P. Mitchell, Consultant fee, Advisory board member (Bayer, Novartis, Allergan, Mylan); S. Leal, Employee, Stockholder (Bayer Consumer Care AG, Pharmaceuticals, Basel, Switzerland), Patent WO2018/229034 pending); T. Schmelter, Employee, Stockholder (Bayer AG, Berlin, Germany); T. Ishibashi, Consultant fee, Advisory board member (Bayer, Novartis, Alcon Pharma, HOYA, Kowa, Bausch + Lomb).